The Nasdaq Biotechnology Index rose over 1.6%, outperforming the three major U.S. stock indices. Cabaletta Bio increased by 26.28%, Altimmune, Prime Medicine, Personalis, and Corvus Pharmaceuticals rose by 16.67%-15.21%, and GRAIL increased by 15.03%. Aardvark Therapeutics fell by 4.68%, Monte Rosa Therapeutics dropped by 4.99%, Bioage Labs decreased by 6.06%, and Legend Bio declined by 6.84%
The Nasdaq Biotechnology Index closed up over 1.6%, outperforming the three major U.S. stock indices.
Component stock Cabaletta Bio rose 26.28%, Altimmune, Prime Medicine, Personalis, and Corvus Pharmaceuticals increased by 16.67%-15.21%, and GRAIL also rose 15.03%.
Aardvark Therapeutics, on the other hand, fell 4.68%, Monte Rosa Therapeutics dropped 4.99%, Bioage Labs decreased by 6.06%, and Legend Bio declined 6.84%